Daikaffil Chemicals India Limited has announced its unaudited financial results for the first quarter ended June 30, 2026. The company reported a net loss of ₹62.73 lakh for the quarter. Total income stood at ₹103.71 lakh, while total expenses were ₹167.34 lakh. The results were approved by the Board of Directors on August 14, 2026, and have undergone a limited review by auditors.
Daikaffil Chemicals Announces Q1 FY27 Results
Daikaffil Chemicals India Limited has disclosed its unaudited standalone financial results for the quarter ended June 30, 2026. The Board of Directors reviewed and approved these results on August 14, 2026.
Financial Performance (Standalone)
For the quarter ended June 30, 2026, the company reported a total income of ₹103.71 lakh, comprising revenue from operations of ₹102.98 lakh and other income of ₹0.73 lakh. Total expenses for the quarter amounted to ₹167.34 lakh. This resulted in a profit/(loss) before exceptional item and tax of ₹(63.63) lakh. After accounting for tax expenses/(credit) of ₹(0.90) lakh, the profit/(loss) for the period after taxes stood at ₹(62.73) lakh.
Other Comprehensive Income (net of taxes) was reported at ₹0.68 lakh, leading to a total comprehensive income for the period of ₹(62.05) lakh. Basic and diluted earnings per share (not annualised for the quarters) were ₹(1.05).
Consolidated Financial Results
The consolidated financial results, which include the company and its subsidiary, also reflect a net loss for the quarter ended June 30, 2026, of ₹67.96 lakh. Total consolidated income was ₹103.71 lakh, with total consolidated expenses at ₹172.57 lakh. The consolidated profit/(loss) before tax was ₹(68.86) lakh.
Other Comprehensive Income (net of taxes) for the consolidated entity was ₹0.48 lakh, resulting in a total comprehensive income for the period of ₹(67.48) lakh. Consolidated basic and diluted earnings per share were ₹(1.13).
Other Information
The financial results have undergone a limited review by the statutory auditors, NVC & Associates LLP, who have issued an unmodified report. The company is engaged in the manufacturing of OBA and Other Chemicals. For the first time, consolidated financial statements have been prepared for the quarter ended December 31, 2025, with comparative information for the quarter ended June 30, 2025, not presented as the company had no subsidiary at that time.
Source: BSE
